Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

21 Aug 2004

Abstract excerpt

This review discusses 26 new anticancer drugs approved by the FDA in the past decade. Based on their targets, these anticancer agents can be divided into three groups. First group contains cancer-selective or semi-selective drugs that are effective in rare kinase- addictive cancers. For other malignancies, semi-selective drugs have to be judiciously combined with nonselective agents. The second group includes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Breast Cancer Therapies
Share to Cancer Genomics and Diagnostics
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15254418
DOI: 10.4161/cc.3.8.1023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer TherapyPMID 15254418Read ↗

How Cancer Could be Cured by 2015Semantic proximity Read ↗

Development of anticancer drugs based on the hallmarks of tumor cells.Semantic proximity Read ↗

Molecular Target and Action Mechanism of Anti-Cancer AgentsSemantic proximity Read ↗

Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesSemantic proximity Read ↗

Targeted Therapies in Cancer: To Be or Not to Be, SelectiveSemantic proximity Read ↗

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and ChallengesSemantic proximity Read ↗

Overview of targeted therapies for cancerSemantic proximity Read ↗

Kinase Inhibitors in Multitargeted Cancer TherapySemantic proximity Read ↗

Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases.Semantic proximity Read ↗

[Clinical manifestation of targeted drugs in individualized therapy of malignant tumors].Semantic proximity Read ↗

Molecular principles underlying aggressive cancersSemantic proximity Read ↗

Mitosis-targeted anti-cancer therapies: where they standSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.